CN107541791A - Construction method, kit and the application in plasma DNA DNA methylation assay library - Google Patents

Construction method, kit and the application in plasma DNA DNA methylation assay library Download PDF

Info

Publication number
CN107541791A
CN107541791A CN201711011500.5A CN201711011500A CN107541791A CN 107541791 A CN107541791 A CN 107541791A CN 201711011500 A CN201711011500 A CN 201711011500A CN 107541791 A CN107541791 A CN 107541791A
Authority
CN
China
Prior art keywords
dna
library
plasma
plasma dna
construction method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711011500.5A
Other languages
Chinese (zh)
Inventor
孙英丽
任善成
常双
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Institute of Genomics of CAS
Original Assignee
Beijing Institute of Genomics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Institute of Genomics of CAS filed Critical Beijing Institute of Genomics of CAS
Priority to CN201711011500.5A priority Critical patent/CN107541791A/en
Publication of CN107541791A publication Critical patent/CN107541791A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of construction method, kit and the application in plasma DNA DNA methylation assay library.Wherein, the construction method comprises the following steps:S1, plasma DNA is extracted from blood sample;S2, end reparation and 3 ' end addition A bases are carried out to plasma DNA;S3, the joint for modification that the end connection C of the obtained plasma DNAs of S2 is methylated;S4, the product obtained to S3 carry out bisulfite conversion, performing PCR of going forward side by side extension;S5, magnetic beads for purifying is carried out to S4 PCR primer, gets rid of the small fragment DNA and primer dimer of non-non-specific amplification;And S6, performing PCR amplification is entered to S5 product, and magnetic beads for purifying is carried out, obtain plasma DNA DNA methylation assay library.Apply the technical scheme of the present invention, reduce conventional trace methylation and build storehouse initial amount, simplify and build storehouse step and improve library organic efficiency, be to screen diagnosing tumor mark subsequently through plasma DNA methylation differential site to lay a good foundation.

Description

Construction method, kit and the application in plasma DNA DNA methylation assay library
Technical field
The present invention relates to biological technical field, in particular to a kind of structure in plasma DNA DNA methylation assay library Construction method, kit and application.
Background technology
Plasma free Circulating tumor DNA (Circulating tumor DNA, ctDNA) refers to by downright bad or apoptosis swollen Oncocyte is discharged into the single-stranded or double-stranded DNA in blood plasma, accounts for the 0.1%-1% of dissociative DNA.CtDNA clip sizes are usual For 160-180bp, half-life period 2 hours, carry SNP (point mutation), InDel (insertion and deletion), CNV (copies in blood Number), fusion (fusion), the information such as methylate.CtDNA constantly flows in blood circulation system, can reflect in real time swollen Knurl patient's current information.
Compared with traditional detection method, ctDNA detections have many advantages:1) sampling is convenient:CtDNA detections need to only draw blood i.e. The parsing to DNA of tumor cell can be completed, the risk of tissue biopsy such as avoids puncturing, perform the operation.2) detection technique is ripe:Utilize two CtDNA is detected for sequencing technologies (NGS), it is sensitive and accurate, false positive rate is low, it can detect as little as 0.1% low frequency mutation.3) examine Survey comprehensive:For the releasable DNA of nearly all tumour cell into blood, ctDNA can embody the comprehensive condition of patient's body tumour.
For the foregoing reasons, ctDNA is expected to turn into the emerging biomarker of clinical detection, diagnosis and curative effect monitoring, accumulates Containing huge clinical value.
DNA methylation refers to add a methyl group on 5C positions in the presence of DNA methylation enzyme in cytimidine, Form 5-methylcytosine.Internal DNA methylation can cause the disease even generation of cancer extremely.DNA methylation detection tool There are very strong stability and tissue specificity, recently research have indicated that the Non-invasive detection of prostate cancer can be realized by DNA methylation (Yao L,Ren S,Zhang M,et al.Identification of specific DNA methylation sites on the Y-chromosome as biomarker in prostate cancer[J].Oncotarget,2015,6(38): 40611.)。
CtDNA DNA methylation assays will have both the advantage of ctDNA detections and DNA methylation detection, and the diagnosis to tumour will have There are higher sensitivity, specificity and diagnostic rate.
CtDNA DNA methylation assays are broadly divided into two classes:The detection of specific site and full-length genome DNA methylation assay.For spy The detection technique of anchor point is based primarily upon PCR, such as:Standard PCR, methylation status of PTEN promoter, qRT-MSP etc..For full-length genome DNA methylation assay, because ctDNA methylation sites concentration is too low, conventional BS-Seq, RRBS, MBD-Seq and MeDIP-Seq are It is inapplicable.With the development of high throughput sequencing technologies, people gradually develop shotgun large-scale parallel sequencing, full-length genome first (MCTA-Seq) technology is sequenced after base CpG Cascaded amplifications, for studying ctDNA full-length genome methylation level.
CfDNA contents are low (more than ten nanograms), therefore conventional trace methylation banking process (initial amount 30-100ng) is no It is applicable.In prior art basis, inventor's Optimal Experimental parameter, the micro database technology that methylates suitable for cfDNA is explored, Invention one is intended to based on the sequencing of two generations, the practicable banking process that methylates, for changing this research field cfDNA methyl Change the predicament in terms of sequencing.
The content of the invention
The present invention is intended to provide a kind of construction method, kit and the application in plasma DNA DNA methylation assay library, with The technical problem in conventional trace methylation banking process structure library can not be used by solving plasma DNA in the prior art.
To achieve these goals, according to an aspect of the invention, there is provided a kind of plasma DNA DNA methylation assay The construction method in library.The construction method comprises the following steps:S1, plasma DNA is extracted from blood sample;S2, to blood Starch dissociative DNA and carry out end reparation and 3 ' end addition A bases;S3, the end of the obtained plasma DNAs of S2 is connected into C methyl Change the joint of modification;S4, the product obtained to S3 carry out bisulfite conversion, performing PCR of going forward side by side extension;S5, S4 PCR is produced Thing carries out magnetic beads for purifying, gets rid of the small fragment DNA and primer dimer of non-non-specific amplification;And S6, to S5 product Enter performing PCR amplification, and carry out magnetic beads for purifying, obtain plasma DNA DNA methylation assay library.
Further, the methylate joints of modification of C are deoxyribonucleoside as shown in SEQ ID NO.1 and SEQ ID NO.2 Acid sequence.
Further, blood sample is patients with prostate cancer blood sample.
Further, the step of construction method also includes carrying out quality testing to the library that structure obtains.
Further, the step of carrying out quality testing to library specifically includes:Library concentration is determined using Qubit, 2% Agarose gel electrophoresis detection library DNA fragment distribution, if DNA fragmentation is distributed in 300bp or so in library, illustrates built text Storehouse is that plasma DNA methylates library;Or library is built using Agilent2100/7500 qualitative and quantitative detections, if 2100/ 7500 peak figure main peak integrated distributions are in 300bp or so, and without miscellaneous peak, then it is that plasma DNA methylates text that explanation, which builds library, Storehouse;Or high-flux sequence is carried out using Illumina Hiseq3000, by bioinformatics means analysis data, assess library Reads mapping rates and conversion ratio, if above parameter is respectively higher than 70.0%, 98.5%, then it is blood plasma that explanation, which builds library, Dissociative DNA methylates library.
According to another aspect of the present invention, there is provided a kind of kit of plasma DNA DNA methylation assay library construction. The kit includes:Plasma DNA extracts reagent, end reparation and the examination of 3 ' end addition A bases are carried out to plasma DNA Agent, C methylate the joint of modification, joint connection reagent, bisulfite conversion reagent, magnetic beads for purifying is carried out to PCR primer Reagent, get rid of the small fragment DNA of non-non-specific amplification and the reagent of primer dimer and the reagent for PCR amplifications.
Further, the methylate joints of modification of C are deoxyribonucleoside as shown in SEQ ID NO.1 and SEQ ID NO.2 Acid sequence.
In accordance with a further aspect of the present invention, there is provided a kind of plasma DNA DNA methylation assay text of construction method structure Application of the storehouse in high-flux sequence.
Further, high-flux sequence is sequenced for Illumina platforms.
Further, plasma DNA comes from patients with prostate cancer blood sample.
Apply the technical scheme of the present invention, reduce conventional trace methylation and build storehouse initial amount, simplify and build storehouse step simultaneously Library organic efficiency is improved, is to screen diagnosing tumor mark subsequently through plasma DNA methylation differential site to establish Basis.
Brief description of the drawings
The Figure of description for forming the part of the application is used for providing a further understanding of the present invention, and of the invention shows Meaning property embodiment and its illustrate be used for explain the present invention, do not form inappropriate limitation of the present invention.In the accompanying drawings:
Fig. 1 shows the quality measurements that plasma DNA is extracted in embodiment 1;
Fig. 2 shows in embodiment 1 that plasma DNA methylates library agarose gel electrophoresis the qualitative analysis;
Fig. 3 shows in embodiment 1 that plasma DNA methylates library quantitative analysis results;
Fig. 4 shows in embodiment 1 that plasma DNA methylates libraries high throughput sequencing reads assessment result cake charts; And
Fig. 5 shows in embodiment 1 that plasma DNA methylates libraries high throughput sequencing reads assessment results.
Embodiment
It should be noted that in the case where not conflicting, the feature in embodiment and embodiment in the application can phase Mutually combination.Describe the present invention in detail below with reference to the accompanying drawings and in conjunction with the embodiments.
According to a kind of typical embodiment of the present invention, there is provided a kind of structure in plasma DNA DNA methylation assay library Method.The construction method comprises the following steps:S1, plasma DNA is extracted from blood sample;S2, plasma DNA is entered Row end is repaired and 3 ' end addition A bases;S3, the joint for modification that the end connection C of the obtained plasma DNAs of S2 is methylated (design principle:F chain 5' ends phosphorylation, all C methylate modification, and all C of R chains methylate modification);S4, the product obtained to S3 Carry out bisulfite conversion, performing PCR of going forward side by side extension;S5, magnetic beads for purifying is carried out to S4 PCR primer, got rid of not non-specific Property amplification small fragment DNA and primer dimer;And S6, performing PCR amplification is entered to S5 product, and magnetic beads for purifying is carried out, obtain To plasma DNA DNA methylation assay library.
Preferably, the methylate joints of modification of C are deoxynucleotide as shown in SEQ ID NO.1 and SEQ ID NO.2 Sequence, sequence are:SEQ ID NO.1(Multiplexing adapters-meth-F(5’->3’): GATCGGAAGAGCACACGTCT, 5 ' end phosphorylations, all C methylate modification;SEQ ID NO.2(Multiplexing adapters-meth-R(5’->3’):ACACTCTTTCCCTACACGACGCTCTTCCGATCT, all C methylate modification.
According to a kind of typical embodiment of the present invention, blood sample is patients with prostate cancer blood sample.
According to a kind of typical embodiment of the present invention, there is provided a kind of plasma DNA DNA methylation assay library construction Kit.The kit includes:Plasma DNA extracts reagent, end reparation and 3 ' end addition A are carried out to plasma DNA Reagent, the C of base methylate modification joint, joint connection reagent, bisulfite conversion reagent, to PCR primer carry out magnetic The reagent of pearl purifying, get rid of the small fragment DNA of non-non-specific amplification and the reagent of primer dimer and expanded for PCR Reagent.
Preferably, the methylate joints of modification of C are deoxynucleotide as shown in SEQ ID NO.1 and SEQ ID NO.2 Sequence.
According to a kind of typical embodiment of the present invention, there is provided a kind of plasma DNA first of above-mentioned construction method structure Baseization detects application of the library in high-flux sequence.
Preferably, high-flux sequence is sequenced for Illumina platforms.
According to a kind of typical embodiment of the present invention, plasma DNA comes from patients with prostate cancer blood sample.
According to a kind of typical embodiment of the present invention, plasma DNA and first are identified by following at least three kinds of methods Whether base library is qualified:
Authentication method one:
The library that the method that storehouse is built by a tubular type DNA methylation is built is subjected to Biology identification, is to utilize first Qubit determines library concentration, 2% agarose gel electrophoresis detection library DNA fragment distribution, if DNA fragmentation is distributed in library In 300bp or so, then it is that plasma DNA methylates library that explanation, which builds library,.
Authentication method two:
The library that the method that storehouse is built by a tubular type DNA methylation is built is subjected to Biology identification, utilized Agilent2100/7500 qualitative and quantitative detections build library, if 2100/7500 peak figure main peak integrated distribution in 300bp or so, And without miscellaneous peak, then it is that plasma DNA methylates library that explanation, which builds library,.
Authentication method three:
The library for the method structure for building storehouse by a tubular type DNA methylation respectively is subjected to Biology identification, utilized Illumina Hiseq3000 carry out high-flux sequence, by bioinformatics means analysis data, assess library reads's The parameters such as mapping rates, conversion ratio, if above parameter is respectively higher than 70.0%, 98.5%, then it is blood plasma trip that explanation, which builds library, From DNA methylation library.
Beneficial effects of the present invention are further illustrated below in conjunction with example.
Embodiment 1
Major experimental step is as follows:
1. the acquisition of plasma sample
EDTA heparin tubes are used under typical laboratory conditions, preferably Streck heparin tubes collect peripheral blood of patients with prostate cancer 10ml, 1900g (or 3000rpm) room temperature Quick spin 10min, absorption upper plasma (avoiding leukocytic cream from polluting) gently arrive New 15ml centrifuge tubes, 16000g room temperatures centrifugation 10min, gently draw supernatant to new 15ml centrifuge tubes.
2. the extraction and quality inspection of plasma DNA
Kai Jie companies are used to be used for the kit for extracting free nucleic acid under typical laboratory conditions, preferably Circulating Nucleic Acid kits, extract dissociative DNA from the blood plasma being separated to specifications, and with 30 μ l Warm water elutes, the plasma DNA extracted by the qualitative and quantitative detections of Agilent 2100, and testing result is as shown in figure 1, specific Illustrated in table 1.
Table 1.Agilent 2100 detects cfDNA result explanations
Jian Ku and storehouse inspection 3. plasma DNA methylates
The plasma DNA of acquisition is built into the library that methylates according to following steps:
1) end-filling and plus A- tails
Using preferable NEB#E7442s enzymes, sample mixing (38.92 μ l systems) in the following proportions:End prep enzyme Mix (1.80 μ l), End repair reaction buffer (3.89 μ l), Fragment DNA samples (30 μ l), λ DNA (3.23μl).Centrifugation, 20 DEG C of incubations 30min, 65 DEG C of incubation 30min.
On the premise of other operation links are consistent, end reparation is attempted respectively plus (sample is successively completed in the modification of A tails Beginning measures:31.75ng) and simultaneously complete (sample initial amount:26.64ng), PCR primer is respectively 3.96 μ g, 4.79 μ g, illustrates one Footwork can effectively avoid sample loss.
2) joint connects
Using preferable NEB#E7445s ligases, sample mixing (50 μ l systems) in the following proportions:Blunt/7A ligase Mix (8.98 μ l), NEB Next adapter (1.50 μ l), Ligation enhance (0.60 μ l), End-repair products (38.92μl).Centrifugation, 20 DEG C of incubation 15min.In the present embodiment, joint sequence (adapters) used includes specific modification, Sequence is:SEQ ID NO.1(Multiplexing adapters-meth-F(5’->3’)): GATCGGAAGAGCACACGTCT, 5 ' end phosphorylations, all C methylate modification;SEQ ID NO.2(Multiplexing adapters-meth-R(5’->3’)):ACACTCTTTCCCTACACGACGCTCTTCCGATCT, all C methylate modification.
3) bisulfite converts
DNA methylation conversion reagent box, preferably EZ DNA Methylation- are used under typical laboratory conditions GoldTMJoint connection product is carried out C- by Kit (Zymo) kits>U is converted.In this experimentation, CT conversion Reagent is formulated as 600 μ l ddH2O+300 μ l M-Dilution Buffer+50 μ l M-Dissolving Buffer, turn It is 98 DEG C of incubations 10min, 64 DEG C of incubation 2h to change program.With 22 μ l warm water eluted dna samples, -20 DEG C freeze.
4) PCR amplifications 1
System (50 μ l):2xKAPA mix(25μl),10μM primer 1.0(2.5μl),10μM index primer 2.0 (2.5 μ l), DNA sample (20 μ l).Program:98℃45s;98 DEG C of 15s, 65 DEG C of 30s, 72 DEG C of 30s;72℃60s;6 are followed Ring.Amplimer is:Primer 1.0SEQ ID NO:3(5’->3’):AATGATACGGCGACCACCGAGATCTACACTCTTTC CCTACACGACGCTCTTCCGATCT;Primer 2 .0SEQ ID NO:4(5’->3’):GTGACTGGAGTT CAGACGTGTGCTCTTCCGATCT。
5) magnetic beads for purifying
1.2 × magnetic bead adsorption step 4) in sample, be stored at room temperature 5min, abandon supernatant.75% ethanol cleans 2 times, 22 μ l temperature Water elution.
6) PCR amplifications 2 (condition primer is with PCR amplifications 1)
7) magnetic bead substep purifies
Large fragment first is adsorbed with 0.6 × magnetic bead, separates supernatant;0.25 × magnetic bead adsorbs foregoing supernatant, stands 5min and abandons Clearly;75% ethanol is washed twice, and the elution of 22 μ l warm water, -20 DEG C freeze.
After cfDNA libraries PCR primer is obtained, glue reclaim method and the recovery of substep paramagnetic particle method, organic efficiency point is respectively adopted Not Wei 7.8%, 34.9%, the latter is approximately the former 4.5 times.
8) storehouse is examined
DNA sample (see Fig. 2,3) in 2% agarose gel electrophoresis, Agilent2100/7500 qualitative, quantitatives 7, specifically It is bright to be shown in Table 2.
Table 2.Agilent 2100 detects cfDNA detection library result explanations
4. plasma DNA methylates, libraries high throughput is sequenced
Library will be built in step 3 and carries out high-flux sequence using Illumina platforms, DNA methylation library sample during upper machine Product and DNA library survey 30G data with 50% ratio sample mixing, each sample, and bioinformatic analysis surveys reads mass, as a result Display:Single-ended reads mapping rates are higher than 70%, C->U high conversion rates are in 98.5% (see Fig. 4,5).Assessment parameter meets pre- Phase, illustrate that built library is qualified.
As can be seen from the above description, the above embodiments of the present invention realize following technique effect:
1) traditional DNA methylation banking process needs to interrupt genomic DNA by physical method, easily causes DNA Fragment is damaged, and the present invention directly extracts plasma DNA, it is not necessary to carries out the processing that traditional DNA sample interrupts, avoids DNA people The hereditary information carried for damage, high-fidelity DNA;
2) traditional minigene group DNA methylation banking process sample initial amount is 30~100ng, and the present invention uses one Since tubular type (expand, all reactions are all implemented in an EP pipe, reduce the sample caused by tube wall adsorbs i.e. building storehouse to PCR Product lose) reduce and build storehouse initial amount, preferably initial amount as little as 10ng;
3) end is repaired and adds the step of A tails one to complete during building storehouse, reduces sample loss;
4) joint sequence used in this method (adapters) includes specific modification, and F chains 5 ' hold phosphorylation, institute on F chains and R chains There is C to methylate modification;
5) glue reclaim method purified pcr product is replaced using substep magnetic bead absorption method, improves product recovery efficiency.
The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention, for the skill of this area For art personnel, the present invention can have various modifications and variations.Within the spirit and principles of the invention, that is made any repaiies Change, equivalent substitution, improvement etc., should be included in the scope of the protection.
Sequence table
<110>Beijing Institute of Gene Science, Chinese Academy of Sciences
<120>Construction method, kit and the application in plasma DNA DNA methylation assay library
<141> 2017-10-26
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<221> primer_bind
<222> (1)..(20)
<223>C methylates the joint of modification
<400> 1
gatcggaaga gcacacgtct 20
<210> 2
<211> 33
<212> DNA
<213> Artificial Sequence
<220>
<221> primer_bind
<222> (1)..(33)
<223>C methylates the joint of modification
<400> 2
acactctttc cctacacgac gctcttccga tct 33
<210> 3
<211> 58
<212> DNA
<213> Artificial Sequence
<220>
<221> primer_bind
<222> (1)..(58)
<223>Amplimer
<400> 3
aatgatacgg cgaccaccga gatctacact ctttccctac acgacgctct tccgatct 58
<210> 4
<211> 34
<212> DNA
<213> Artificial Sequence
<220>
<221> primer_bind
<222> (1)..(34)
<223>Amplimer
<400> 4
gtgactggag ttcagacgtg tgctcttccg atct 34

Claims (10)

1. a kind of construction method in plasma DNA DNA methylation assay library, it is characterised in that comprise the following steps:
S1, plasma DNA is extracted from blood sample;
S2, end reparation and 3 ' end addition A bases are carried out to the plasma DNA;
S3, the joint for modification that the end connection C of the obtained plasma DNAs of the S2 is methylated;
S4, the product obtained to the S3 carry out bisulfite conversion, performing PCR of going forward side by side extension;
S5, magnetic beads for purifying is carried out to the PCR primer of the S4, gets rid of the small fragment DNA and primer two of non-non-specific amplification Aggressiveness;And
S6, performing PCR amplification is entered to the product of the S5, and carry out magnetic beads for purifying, obtain the plasma DNA DNA methylation assay Library.
2. construction method according to claim 1, it is characterised in that the methylate joints of modification of the C are such as SEQ ID Deoxynucleotide sequence shown in NO.1 and SEQ ID NO.2.
3. construction method according to claim 1, it is characterised in that the blood sample is patients with prostate cancer blood sample This.
4. construction method according to claim 1, it is characterised in that the construction method also includes the text obtained to structure Storehouse carries out the step of quality testing.
5. construction method according to claim 4, it is characterised in that described the step of carrying out quality testing to library is specific Including:
Library concentration, 2% agarose gel electrophoresis detection library DNA fragment distribution, if DNA in library are determined using Qubit Fragment is distributed in 300bp or so, then it is that plasma DNA methylates library that explanation, which builds library,;Or
Library is built using Agilent2100/7500 qualitative and quantitative detections, if 2100/7500 peak figure main peak integrated distribution exists 300bp or so, and without miscellaneous peak, then it is that plasma DNA methylates library that explanation, which builds library,;Or
High-flux sequence is carried out using Illumina Hiseq3000, by bioinformatics means analysis data, assesses library Reads mapping rates and conversion ratio, if above parameter is respectively higher than 70.0%, 98.5%, then it is blood plasma that explanation, which builds library, Dissociative DNA methylates library.
A kind of 6. kit of plasma DNA DNA methylation assay library construction, it is characterised in that including:Plasma DNA carries Take reagent, end reparation carried out to plasma DNA and 3 ' ends are added reagent, the C of A bases and methylated joint, the joint of modification Reagent, bisulfite conversion reagent, the reagent that magnetic beads for purifying is carried out to PCR primer are connected, gets rid of non-non-specific amplification Small fragment DNA and primer dimer reagent and for PCR amplification reagent.
7. kit according to claim 1, it is characterised in that the methylate joints of modification of the C are such as SEQ ID Deoxynucleotide sequence shown in NO.1 and SEQ ID NO.2.
8. a kind of plasma DNA DNA methylation assay library of the structure of the construction method as any one of claim 1 to 5 exists Application in high-flux sequence.
9. application according to claim 8, it is characterised in that the high-flux sequence is sequenced for Illumina platforms.
10. application according to claim 8, it is characterised in that the plasma DNA comes from patients with prostate cancer blood Sample.
CN201711011500.5A 2017-10-26 2017-10-26 Construction method, kit and the application in plasma DNA DNA methylation assay library Pending CN107541791A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711011500.5A CN107541791A (en) 2017-10-26 2017-10-26 Construction method, kit and the application in plasma DNA DNA methylation assay library

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711011500.5A CN107541791A (en) 2017-10-26 2017-10-26 Construction method, kit and the application in plasma DNA DNA methylation assay library

Publications (1)

Publication Number Publication Date
CN107541791A true CN107541791A (en) 2018-01-05

Family

ID=60967177

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711011500.5A Pending CN107541791A (en) 2017-10-26 2017-10-26 Construction method, kit and the application in plasma DNA DNA methylation assay library

Country Status (1)

Country Link
CN (1) CN107541791A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108300787A (en) * 2018-04-17 2018-07-20 中国科学院北京基因组研究所 Special application of the methylation sites as early diagnosing mammary cancer marker
CN108531593A (en) * 2018-04-17 2018-09-14 中国科学院北京基因组研究所 Special application of the methylation sites as breast cancer relapse diagnosis marker
CN108676879A (en) * 2018-05-24 2018-10-19 中国科学院北京基因组研究所 Special application of the methylation sites as breast cancer molecular classification diagnosis marker
CN108796039A (en) * 2018-06-29 2018-11-13 上海交通大学 A kind of kit and method and application for DNA methylation detection
CN108866192A (en) * 2018-07-26 2018-11-23 上海奕谱生物科技有限公司 Tumor marker STAMP-EP1 based on methylation modification
CN110305946A (en) * 2019-07-18 2019-10-08 重庆大学附属肿瘤医院 DNA methylation detection method based on high-flux sequence
CN110669824A (en) * 2019-10-11 2020-01-10 广州迈森致远基因科技有限公司 Kit and method for methylation library construction of low-initial-amount plasma free DNA
CN111411144A (en) * 2020-04-21 2020-07-14 深圳华大因源医药科技有限公司 Plasma free DNA marker for diagnosis of blood stream infection pathogen
CN111575347A (en) * 2020-05-19 2020-08-25 清华大学 Method for constructing library for simultaneously obtaining free DNA methylation and fragmentation pattern information in plasma
WO2020232635A1 (en) * 2019-05-21 2020-11-26 深圳华大智造科技有限公司 Method and system for constructing sequencing library on the basis of methylated dna target region, and use thereof
CN112080555A (en) * 2019-06-14 2020-12-15 上海鹍远健康科技有限公司 DNA methylation detection kit and detection method
CN112126987A (en) * 2020-08-19 2020-12-25 深圳思凝一云科技有限公司 Library construction method for sequencing methylation amplicon
CN112143778A (en) * 2020-09-11 2020-12-29 昂凯生命科技(苏州)有限公司 Method for extracting and transforming free DNA of blood plasma and application thereof
WO2021169875A1 (en) * 2020-02-25 2021-09-02 博尔诚(北京)科技有限公司 Cancer gene methylation measuring system and cancer in vitro detection method executed in same
CN113832140A (en) * 2021-09-24 2021-12-24 中国人民解放军陆军军医大学 DNA methylation site logarithmic quantity detection method for electrochemical immunization
CN114606316A (en) * 2022-03-12 2022-06-10 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) Construction method of model for early diagnosis and prognosis prediction of NK/T cell lymphoma
CN115404270A (en) * 2022-10-31 2022-11-29 臻和(北京)生物科技有限公司 Evaluation method of methylation conversion rate of DNA methylation sequencing library, application, terminal equipment and storage medium
CN116555426A (en) * 2023-05-04 2023-08-08 杭州圣庭医疗科技有限公司 Kit for identifying tumor tissue sources and data analysis method

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102409408A (en) * 2010-09-21 2012-04-11 深圳华大基因科技有限公司 Method for accurate detection of whole genome methylation sites by utilizing trace genome DNA (deoxyribonucleic acid)
CN103088433A (en) * 2011-11-02 2013-05-08 深圳华大基因科技有限公司 Construction method and application of genome-wide methylation high-throughput sequencing library and
CN104372079A (en) * 2014-10-24 2015-02-25 中国科学院遗传与发育生物学研究所 Sequencing method and application of methylated DNA
CN105442054A (en) * 2015-11-19 2016-03-30 杭州谷坤生物技术有限公司 Method for performing multi-target-site amplification library construction on plasma free DNA (deoxyribonucleic acid)
CN105695448A (en) * 2016-03-11 2016-06-22 浙江圣庭生物科技有限公司 Construction method of blood free DNA (deoxyribonucleic acid) library based on Ion ProtonTM sequencing platform, reagents and application of reagents
CN106811460A (en) * 2015-11-30 2017-06-09 安诺优达基因科技(北京)有限公司 For the construction method and kit of two generation sequencing libraries of low frequency abrupt climatic change
CN106834275A (en) * 2017-02-22 2017-06-13 天津诺禾医学检验所有限公司 The analysis method of the construction method, kit and library detection data in ctDNA ultralow frequency abrupt climatic changes library
CN106868124A (en) * 2017-02-20 2017-06-20 昆明理工大学 One group of methylated genes and its detection method
CN106867995A (en) * 2017-03-01 2017-06-20 安徽安科生物工程(集团)股份有限公司 CfDNA builds joint, primer sets, kit and the banking process in storehouse

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102409408A (en) * 2010-09-21 2012-04-11 深圳华大基因科技有限公司 Method for accurate detection of whole genome methylation sites by utilizing trace genome DNA (deoxyribonucleic acid)
CN103088433A (en) * 2011-11-02 2013-05-08 深圳华大基因科技有限公司 Construction method and application of genome-wide methylation high-throughput sequencing library and
CN104372079A (en) * 2014-10-24 2015-02-25 中国科学院遗传与发育生物学研究所 Sequencing method and application of methylated DNA
CN105442054A (en) * 2015-11-19 2016-03-30 杭州谷坤生物技术有限公司 Method for performing multi-target-site amplification library construction on plasma free DNA (deoxyribonucleic acid)
CN106811460A (en) * 2015-11-30 2017-06-09 安诺优达基因科技(北京)有限公司 For the construction method and kit of two generation sequencing libraries of low frequency abrupt climatic change
CN105695448A (en) * 2016-03-11 2016-06-22 浙江圣庭生物科技有限公司 Construction method of blood free DNA (deoxyribonucleic acid) library based on Ion ProtonTM sequencing platform, reagents and application of reagents
CN106868124A (en) * 2017-02-20 2017-06-20 昆明理工大学 One group of methylated genes and its detection method
CN106834275A (en) * 2017-02-22 2017-06-13 天津诺禾医学检验所有限公司 The analysis method of the construction method, kit and library detection data in ctDNA ultralow frequency abrupt climatic changes library
CN106867995A (en) * 2017-03-01 2017-06-20 安徽安科生物工程(集团)股份有限公司 CfDNA builds joint, primer sets, kit and the banking process in storehouse

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RUI-HUA XU等: "Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma", 《NATURE MATERIALS》 *

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108531593A (en) * 2018-04-17 2018-09-14 中国科学院北京基因组研究所 Special application of the methylation sites as breast cancer relapse diagnosis marker
CN108300787A (en) * 2018-04-17 2018-07-20 中国科学院北京基因组研究所 Special application of the methylation sites as early diagnosing mammary cancer marker
CN108676879A (en) * 2018-05-24 2018-10-19 中国科学院北京基因组研究所 Special application of the methylation sites as breast cancer molecular classification diagnosis marker
CN108796039A (en) * 2018-06-29 2018-11-13 上海交通大学 A kind of kit and method and application for DNA methylation detection
CN108796039B (en) * 2018-06-29 2021-10-08 上海交通大学 Kit and method for DNA methylation detection and application
CN108866192A (en) * 2018-07-26 2018-11-23 上海奕谱生物科技有限公司 Tumor marker STAMP-EP1 based on methylation modification
WO2020232635A1 (en) * 2019-05-21 2020-11-26 深圳华大智造科技有限公司 Method and system for constructing sequencing library on the basis of methylated dna target region, and use thereof
CN112080555A (en) * 2019-06-14 2020-12-15 上海鹍远健康科技有限公司 DNA methylation detection kit and detection method
CN110305946A (en) * 2019-07-18 2019-10-08 重庆大学附属肿瘤医院 DNA methylation detection method based on high-flux sequence
CN110669824A (en) * 2019-10-11 2020-01-10 广州迈森致远基因科技有限公司 Kit and method for methylation library construction of low-initial-amount plasma free DNA
WO2021169875A1 (en) * 2020-02-25 2021-09-02 博尔诚(北京)科技有限公司 Cancer gene methylation measuring system and cancer in vitro detection method executed in same
CN111411144A (en) * 2020-04-21 2020-07-14 深圳华大因源医药科技有限公司 Plasma free DNA marker for diagnosis of blood stream infection pathogen
CN111411144B (en) * 2020-04-21 2023-12-22 深圳华大因源医药科技有限公司 Plasma free DNA marker for diagnosing blood flow infection pathogen
CN111575347A (en) * 2020-05-19 2020-08-25 清华大学 Method for constructing library for simultaneously obtaining free DNA methylation and fragmentation pattern information in plasma
CN112126987A (en) * 2020-08-19 2020-12-25 深圳思凝一云科技有限公司 Library construction method for sequencing methylation amplicon
CN112143778A (en) * 2020-09-11 2020-12-29 昂凯生命科技(苏州)有限公司 Method for extracting and transforming free DNA of blood plasma and application thereof
CN113832140A (en) * 2021-09-24 2021-12-24 中国人民解放军陆军军医大学 DNA methylation site logarithmic quantity detection method for electrochemical immunization
CN114606316A (en) * 2022-03-12 2022-06-10 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) Construction method of model for early diagnosis and prognosis prediction of NK/T cell lymphoma
CN115404270A (en) * 2022-10-31 2022-11-29 臻和(北京)生物科技有限公司 Evaluation method of methylation conversion rate of DNA methylation sequencing library, application, terminal equipment and storage medium
CN115404270B (en) * 2022-10-31 2023-01-31 臻和(北京)生物科技有限公司 Evaluation method of methylation conversion rate of DNA methylation sequencing library, application, terminal equipment and storage medium
CN116555426A (en) * 2023-05-04 2023-08-08 杭州圣庭医疗科技有限公司 Kit for identifying tumor tissue sources and data analysis method

Similar Documents

Publication Publication Date Title
CN107541791A (en) Construction method, kit and the application in plasma DNA DNA methylation assay library
CN109609647B (en) Detection Panel for pan-cancer-species targeting, chemotherapy and immune drugs based on next-generation sequencing, detection kit and application thereof
Lee et al. Genome-wide methylation profiling and a multiplex construction for the identification of body fluids using epigenetic markers
CN106906211B (en) Molecular joint and application thereof
CN107475375A (en) A kind of DNA probe storehouse, detection method and kit hybridized for microsatellite locus related to microsatellite instability
CN105442054B (en) The method that storehouse is built in the amplification of multiple target site is carried out to plasma DNA
CN109797197A (en) It a kind of single chain molecule label connector and single stranded DNA banking process and its is applied in detection Circulating tumor DNA
CN110257480A (en) Nucleic acid sequence sequence measuring joints and its method for constructing sequencing library
CN108300716A (en) Joint component, its application and the method that targeting sequencing library structure is carried out based on asymmetric multiplex PCR
CN112176057B (en) Marker for detecting pancreatic duct adenocarcinoma by using CpG site methylation level and application thereof
CN108753954B (en) Capture probe set of dementia-related gene, kit, library construction method and application
WO2016049878A1 (en) Snp profiling-based parentage testing method and application
CN106834507A (en) DMD gene traps probe and its application in DMD detection in Gene Mutation
CN108004304A (en) A kind of Clonal method for detecting lymphocyte related genes and resetting
CN109576346A (en) The construction method of high-throughput sequencing library and its application
CN107142320B (en) Gene marker for detecting liver cancer and application thereof
CN110760936A (en) Method for constructing DNA methylation library and application thereof
CN115786459B (en) Method for detecting tiny residual disease of solid tumor by high-throughput sequencing
WO2019076018A1 (en) Method for constructing amplicon library for detecting low-frequency mutation of target gene
CN106995851A (en) Expand PCR primer, the kit of detection PKD1 gene mutations and the application of PKD1 extron overlength fragments
CN111304288A (en) Specific molecular tag UMI group and application thereof
CN109385469A (en) A kind of high sensitivity double-strand Circulating tumor DNA detection method and kit
CN106191311A (en) A kind of quick detection Cavia porcellus LCMV, SV, PVM, Reo 3 virus multiple liquid phase method for gene chip and reagent
CN104450872A (en) High-throughput multi-sample multi-target sing-base resolution methylation level detection method
CN101555528B (en) Method for testing chromosome 22q11.2 microdeletion and microduplication

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180105

RJ01 Rejection of invention patent application after publication